Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GX 19N

Next Previous
Drug Profile

GX 19N

Alternative Names: GX-19N

Latest Information Update: 28 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genexine
  • Class COVID-19 vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II/III COVID 2019 infections

Most Recent Events

  • 28 Mar 2024 No recent reports of development identified for phase-I development in COVID-2019-infections(In the elderly, Prevention) in South Korea (IM, Injection)
  • 12 Apr 2022 Genexine withdraws its phase II/III trial in COVID-2019 infections due to change of development strategy in consideration of the global COVID-19 situation (NCT05067946)
  • 01 Apr 2022 Genexine completes a phase I trial in COVID-2019 infections (In the elderly, Prevention) in South Korea (IM) (NCT04915989)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top